G0103 HCPCS Level II code: Prostate cancer screening; prostate specific antigen test (psa)
G0103 is the HCPCS code for “Prostate cancer screening; prostate specific antigen test (psa)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G0103Prostate cancer screening; prostate specific antigen test (psa)
Short description: Psa screening
HCPCS · United States
Notes for G0103
As CMS prints them, with any note G0103 takes from the headings above it.
Note
- CMS processing note 0064: COVERAGE AND PAYMENT BASED ON BALANCED BUDGET ACT OF 1997 (G0101 - SEC 4102; G0104, G0105, G0106, G0107, G0120, G0121, G0122, G0128 - SEC 4104).
Medicare details
The indicators CMS publishes with G0103 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Clinical lab fee schedule – Price subject to national limitation amount
- Type of service
- Diagnostic laboratory
- BETOS category
- Lab tests - other (Non-Medicare fee schedule)
- Lab certification
- Routine chemistry
- Added
- Jan 1, 2000
Where G0103 sits
- 1G codesProcedures and professional services
- 2Active code G0103Prostate cancer screening; prostate specific antigen test (psa)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G0103 mean?
G0103 is the HCPCS code for “Prostate cancer screening; prostate specific antigen test (psa)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G0103?
CMS lists G0103’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Clinical lab fee schedule – Price subject to national limitation amount”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G0103
All G codesG0087Comprehensive (60 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home…G0088Professional services, initial visit, for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug…G0089Professional services, initial visit, for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration…G0090Professional services, initial visit, for the administration of intravenous chemotherapy or other highly complex infusion drug or biological for each infusion drug administration…G0101Cervical or vaginal cancer screening; pelvic and clinical breast examinationG0102Prostate cancer screening; digital rectal examinationG0104Colorectal cancer screening; flexible sigmoidoscopyG0105Colorectal cancer screening; colonoscopy on individual at high riskG0106Colorectal cancer screening; alternative to g0104, screening sigmoidoscopy, barium enemaG0108Diabetes outpatient self-management training services, individual, per 30 minutesG0109Diabetes outpatient self-management training services, group session (2 or more), per 30 minutesG0117Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist